One Platform, Many Markets

Applications

BioCapZ is a single delivery platform built to serve multiple markets. Explore the areas below to see where it fits.

Nanocapsid delivering imaging agents into a tumor under AI-guided targeting

Precision Cancer Therapeutics & Imaging

BioCapZ supports theranostic applications that combine diagnosis and treatment in one platform. Loaded with imaging agents (MRI/PET), it enables AI-guided, image-directed tumor treatment — including targeted hyperthermia approaches designed to treat tumors with minimal impact to surrounding healthy tissue.

Who it's for: Oncology drug developers and diagnostic imaging partners.

Capsule releasing gene-editing payloads that survive the stomach for oral delivery

Delivering Complex Biologics Without a Needle

The capsid is stable enough to survive the stomach environment, enabling oral delivery of biologics that normally require injection — including proteins, peptides, nucleic acids, and CRISPR gene-editing tools. This has been demonstrated with successful oral delivery of gene-editing payloads in preclinical models.

Who it's for: Biologics and gene-therapy developers looking to move beyond injectables.

Nanocapsid displaying multiple antigen copies activating surrounding immune cells

Built-In Immune Enhancement

The BioCapZ capsid is itself immunogenic and can display multiple antigen copies on its surface, enhancing immune presentation and driving a stronger, more targeted response (including MHC Class I & II activation). This structural immunogenicity allows BioCapZ to act as a built-in adjuvant platform, reducing or eliminating the need for separate chemical adjuvants.

Who it's for: Vaccine developers seeking stronger immune response without added adjuvant complexity.

Livestock in an open field receiving needle-free oral vaccination via nanocapsids

Simplifying Veterinary & Livestock Immunization

Ambient-temperature stability and needle-free oral/mucosal administration make BioCapZ well suited to veterinary and livestock vaccination — removing the need for cold-chain logistics or injection equipment in field and herd-level settings.

Who it's for: Animal health companies and veterinary vaccine developers.

Don't see your application listed?

BioCapZ is a modular platform — if your program involves targeted delivery, immune activation, or oral/mucosal administration, it likely applies.